WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Osteoporosis Efficacy Criteria v6, Dual energy x-ray absorptiometry (DXA) performed at Defined by protocol Time points, Concepts proposed for removal from CMAP are denoted by grey color boxes, T-score assessed only secondarily for 1/3 distal radius, FDA Efficacy Criteria for Osteoporosis additional variables for efficacy consideration Concomitant Medications, Concomitant Medications instantiated_by Concomitant Medications, Blood for serum biomarkers, Radiographic Test performed at Time points defined by protocol, Biochemical markers of bone turnover obtained from testing Urine, Radiographic Test classified by Quantitative Morphometry, T-score measured in units Standard Deviations (SD), Radiographic Test performed at Time Points defined by symptoms, Concepts are denoted by solid round-edged rectangle, Non-vertebral fracture is confirmed by Radiographic Test, Semi-Quantitative Assessment assesses Vertebral shape, Vertebral shape instantiated by Types of vertebral shapes, Semi-Quantitative Assessment measured for vertebrae T4 - L5, Biochemical markers of bone turnover obtained from testing Blood, Blood for serum c-telopeptides (CTx), The proportion of patients with fracture has outcome assessment Non-vertebral fracture, Radiographic Test classified by Semi-Quantitative Assessment